Display options
Cite
Nilsson S. CORRIGENDUM to 'Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis'. Cephalalgia. 2021;3331024211042798doi: 10.1177/03331024211042798.
Nilsson, S. (2021). CORRIGENDUM to 'Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis'. Cephalalgia : an international journal of headache, 3331024211042798. https://doi.org/10.1177/03331024211042798
Nilsson. "CORRIGENDUM to 'Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis'." Cephalalgia : an international journal of headache vol. (2021): 3331024211042798. doi: https://doi.org/10.1177/03331024211042798
Nilsson S. CORRIGENDUM to 'Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis'. Cephalalgia. 2021 Sep 14;3331024211042798. doi: 10.1177/03331024211042798. Epub 2021 Sep 14. PMID: 34521262.
Copy Download .nbib Format: NLM
Share it on

Cephalalgia. 2021 Sep 14;3331024211042798. doi: 10.1177/03331024211042798. Epub 2021 Sep 14.

CORRIGENDUM to 'Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis'.

Cephalalgia : an international journal of headache

Nilsson

PMID: 34521262 DOI: 10.1177/03331024211042798

[No abstract available.]

Publication Types